HIGHLIGHTS
- who: TMPRSS et al. from the University of Isfahan, Iran have published the research work: TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune In fi ltrates in Breast Invasive Cancer and Lung Adenocarcinoma, in the Journal: (JOURNAL)
- what: The authors systematically analyzed and further detected the expression of TMPRSS2 in tumors and adjacent tissues through qRT-PCR and then analyzed prognosis by several databases such as Oncomine, TIMER, PrognoScan, GEPIA, and Kaplan-Meier plotter. The authors demonstrated that TMPRSS2 affects the prognosis of LUAD and BRCA through tumor immune cell infiltration, and the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.